Danaher Corporation (DHR)
Healthcare • Diagnostics & Research
StockNYSEUnited StatesUS2358511028
230.66 USD
-0.65% today Updated 13 Nov 2026 16:27
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Danaher Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:27. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
27 Jan 2027
in 75 days · 08:00 · estimate 2.48
Last results
2.11 vs 1.92 estimated
21 Oct 2026 · Beat +10.0%
Beat the estimate
11 of 12
1 missed · 0 in line · 7 beats in a row
Average surprise
+8.0%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 27 Jan 2027 08:00 | 2.48 | — | — | Upcoming |
| 21 Oct 2026 06:00 | 1.92 | 2.11 | +10.0% | Beat |
| 21 Jul 2026 06:00 | 1.84 | 1.94 | +5.3% | Beat |
| 21 Apr 2026 06:00 | 1.94 | 2.06 | +6.5% | Beat |
| 28 Jan 2026 06:00 | 2.19 | 2.23 | +2.0% | Beat |
| 21 Oct 2025 06:00 | 1.72 | 1.89 | +9.8% | Beat |
| 22 Jul 2025 06:00 | 1.64 | 1.80 | +9.5% | Beat |
| 22 Apr 2025 06:00 | 1.64 | 1.88 | +14.4% | Beat |
| 29 Jan 2025 06:00 | 2.16 | 2.14 | -1.1% | Miss |
| 22 Oct 2024 06:00 | 1.57 | 1.71 | +8.9% | Beat |
| 23 Jul 2024 06:00 | 1.57 | 1.72 | +9.3% | Beat |
| 23 Apr 2024 06:00 | 1.71 | 1.92 | +12.4% | Beat |
| 30 Jan 2024 06:00 | 1.91 | 2.09 | +9.2% | Beat |
| 24 Oct 2023 06:00 | 1.88 | 2.02 | +7.6% | Beat |
| 25 Jul 2023 06:00 | 2.02 | 2.05 | +1.7% | Beat |
| 25 Apr 2023 06:00 | 2.26 | 2.36 | +4.4% | Beat |
| 24 Jan 2023 06:00 | 2.55 | 2.87 | +12.6% | Beat |
| 20 Oct 2022 06:00 | 2.25 | 2.56 | +13.5% | Beat |
| 21 Jul 2022 06:00 | 2.34 | 2.76 | +18.1% | Beat |
| 21 Apr 2022 06:00 | 2.66 | 2.76 | +3.6% | Beat |
| 27 Jan 2022 06:00 | 2.54 | 2.69 | +6.0% | Beat |
| 21 Oct 2021 06:00 | 2.15 | 2.39 | +11.0% | Beat |
| 22 Jul 2021 06:00 | 2.05 | 2.46 | +20.0% | Beat |
| 22 Apr 2021 06:00 | 1.77 | 2.52 | +42.1% | Beat |
| 28 Jan 2021 06:00 | 1.88 | 2.08 | +10.9% | Beat |
| 22 Oct 2020 06:00 | 1.36 | 1.72 | +26.4% | Beat |
| 23 Jul 2020 06:00 | 1.09 | 1.44 | +31.9% | Beat |
| 06 May 2020 17:00 | 1.02 | 1.05 | +2.7% | Beat |
| 30 Jan 2020 06:00 | 1.25 | 1.28 | +2.3% | Beat |
| 24 Oct 2019 06:00 | 1.15 | 1.16 | +0.8% | In line |
| 18 Jul 2019 06:00 | 1.16 | 1.19 | +2.5% | Beat |
| 18 Apr 2019 06:00 | 1.02 | 1.07 | +5.0% | Beat |
| 29 Jan 2019 06:00 | 1.27 | 1.28 | +0.6% | In line |
| 18 Oct 2018 06:00 | 1.08 | 1.10 | +2.3% | Beat |
| 19 Jul 2018 06:00 | 1.09 | 1.15 | +5.9% | Beat |
| 19 Apr 2018 06:00 | 0.94 | 0.99 | +5.2% | Beat |
| 30 Jan 2018 06:00 | 1.16 | 1.19 | +2.8% | Beat |
| 19 Oct 2017 06:00 | 0.95 | 1.00 | +4.9% | Beat |
| 20 Jul 2017 06:00 | 0.97 | 0.99 | +2.3% | Beat |
| 20 Apr 2017 06:00 | 0.84 | 0.85 | +0.9% | In line |
| 31 Jan 2017 06:00 | 1.03 | 1.05 | +1.9% | Beat |
| 20 Oct 2016 06:00 | 0.82 | 0.87 | +5.5% | Beat |
| 25 Jul 2016 06:00 | 1.22 | 1.25 | +2.1% | Beat |
| 21 Apr 2016 06:00 | 1.03 | 1.08 | +4.9% | Beat |
| 26 Jan 2016 06:00 | 1.27 | 1.27 | +0.2% | In line |
| 22 Oct 2015 06:00 | 1.04 | 1.05 | +1.3% | Beat |
| 23 Jul 2015 06:00 | 1.04 | 1.08 | +4.3% | Beat |
| 23 Apr 2015 06:00 | 0.93 | 0.93 | -0.2% | In line |
| 27 Jan 2015 06:00 | 1.04 | 1.04 | +0.5% | In line |
| 16 Oct 2014 06:00 | 0.89 | 0.90 | +0.9% | In line |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 24.6B | +2.9% | 3.6B | 14.7% | 5.05 | -4.5% | 5.3B |
| 2024 | 23.9B | -0.1% | 3.9B | 16.3% | 5.29 | -17.1% | 5.3B |
| 2023 | 23.9B | -10.3% | 4.8B | 19.9% | 6.38 | -34.0% | 5.8B |
| 2022 | 26.6B | — | 7.2B | 27.1% | 9.66 | — | 7.4B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 231.63 | 237.95 | 228.37 | 230.66 | +0.18% | 13,345,412 | |
| 02 Nov 2026 – 06 Nov 2026 | 234.20 | 238.45 | 222.96 | 230.25 | -0.85% | 18,100,100 | |
| 26 Oct 2026 – 30 Oct 2026 | 230.94 | 238.46 | 229.32 | 232.23 | +0.75% | 15,213,400 | |
| 19 Oct 2026 – 23 Oct 2026 | 229.01 | 238.13 | 217.55 | 230.50 | +0.64% | 33,560,900 | |
| 12 Oct 2026 – 16 Oct 2026 | 220.72 | 233.02 | 219.11 | 229.04 | +4.20% | 21,250,900 | |
| 05 Oct 2026 – 09 Oct 2026 | 213.81 | 227.61 | 211.72 | 219.81 | +2.69% | 19,937,400 | |
| 28 Sep 2026 – 02 Oct 2026 | 223.40 | 228.38 | 211.18 | 214.06 | -4.65% | 23,005,000 | 0.4000 |
| 21 Sep 2026 – 25 Sep 2026 | 212.03 | 226.65 | 209.60 | 224.49 | +5.99% | 23,818,400 | |
| 14 Sep 2026 – 18 Sep 2026 | 202.48 | 214.98 | 199.09 | 211.81 | +5.83% | 25,509,200 | |
| 08 Sep 2026 – 11 Sep 2026 | 205.00 | 207.84 | 199.16 | 200.14 | -3.62% | 12,699,000 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Danaher (DHR) Is A Key Supplier In Fast Growing Bioprocessing Markets (opens in a new tab) Simply Wall St. · 12 Nov 2026 19:09
- A Memo To Danaher's Biotechnology Team About Turning Orders Into Sales (opens in a new tab) Trefis · 12 Nov 2026 15:13
- Microfluidic Device Systems - Global Strategic Business Report 2026: Capitalize on 8.7% CAGR to $11.1 Billion by 2032 | Abbott, Danaher, Bio-Rad, and Siemens Healthineers Shape the Competition (opens in a new tab) 12 Nov 2026 14:57
- Tangential Flow Filtration - Global Strategic Business Report 2026: Capitalize on a $2B Revenue Shift to $3.6B by 2032 as Danaher, MilliporeSigma, GE Healthcare, and Alfa Laval Accelerate Competition (opens in a new tab) 12 Nov 2026 14:56
- Single-Use Bioprocessing - Global Strategic Business Report 2026: Capitalize on 13.4% CAGR to $47.7B by 2032, Featuring Profiles of Danaher, Thermo Fisher Scientific, 3M, and Eppendorf (opens in a new tab) 12 Nov 2026 14:54
- Danaher’s Cepheid business to lay off 67 people in California (opens in a new tab) MedTech Dive · 11 Nov 2026 15:57
- Global Biotechnology Market to Reach $5 Trillion by 2032, Driven by Biopharmaceuticals, Gene Editing and Sustainable Innovation | Features Profiles of Danaher, Roche, Illumina, Merck, Thermo Fisher and More (opens in a new tab) 11 Nov 2026 14:44
- Genomics - Global Strategic Business Report 2026: Capitalize on the $117.3 Billion Market by 2032, Featuring Strategic Intelligence on Illumina, Thermo Fisher Scientific, Danaher, and Oxford Nanopore (opens in a new tab) 11 Nov 2026 14:14
- Insider Move: Matthew McGrew Exercises Options, Realizing $2.56M At Danaher (opens in a new tab) Benzinga · 11 Nov 2026 11:01
- VTRS or DHR: Which Is the Better Value Stock Right Now? (opens in a new tab) Zacks · 10 Nov 2026 19:38
- A $36 Billion Fund Bought These 3 Stocks (opens in a new tab) TIKR · 10 Nov 2026 16:52
- Capillary Electrophoresis - Global Strategic Business Report: Secure Share of the $1.1 Billion Market by 2032 as Agilent, Bio-Rad, Danaher and Thermo Fisher Accelerate CE-MS Innovation (opens in a new tab) 10 Nov 2026 15:11
- Single-Use Bioreactors - Global Strategic Business Report: Capitalize on 17.5% CAGR to $18.9B by 2032 as Danaher, Sartorius, Eppendorf and PBS Biotech Accelerate Biomanufacturing (opens in a new tab) 10 Nov 2026 15:03
- Nucleic Acid Isolation and Purification - Global Strategic Business Report: Capture the $3.9 Billion Revenue Surge by 2030 as Thermo Fisher, Qiagen, Danaher, Illumina, and Bio-Rad Battle for Share (opens in a new tab) 10 Nov 2026 15:02
- Danaher CEO Sees Faster Growth Ahead, With AI and Acquisitions in Focus (opens in a new tab) MarketBeat · 10 Nov 2026 00:14
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 232.16 USD
- Market cap
- 163.3B
- Dividend yield
- 0.69%
- 5-year average yield
- 0.44%
- Payout ratio
- 25%
- Last dividend
- 0.4000 USD · 30 Sep 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 30 Sep 2026 | 0.4000 USD |
| 26 Jun 2026 | 0.4000 USD |
| 27 Mar 2026 | 0.4000 USD |
| 26 Dec 2025 | 0.3200 USD |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow DHR and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.